Applied Molecular Transport Inc.
DelistedCIK 1801777fmd_0ZMN2X1XAJZFV85QZC2NGAH658Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2023, 19 periods
Latest annual · FY2022
Millions- Operating income
- (127)
- Net income
- (126)
- Free cash flow
- (98)
Latest quarter · Q3 FY2023
Millions- Operating income
- (7)
- Net income
- (7)
- Free cash flow
- (4)
Applied Molecular Transport Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Operating income | -$127.2 million | -$100.8 million | 10-K 2023-03-09 · proof | |
| Net income | -$126.3 million | -$100.3 million | 10-K 2023-03-09 · proof | |
| Cash from operating activities | -$93.9 million | -$82.6 million | 10-K 2023-03-09 · proof | |
| Free cash flow | -$98.1 million | -$84.5 million | 10-K 2023-03-09 · proof | |
| Total assets | $107.4 million | $214 million | -49.8% | 10-K 2023-03-09 · proof |
| Total liabilities | $46.6 million | $50.5 million | -7.6% | 10-K 2023-03-09 · proof |
| Cash and cash equivalents | $61.1 million | $159.8 million | -61.7% | 10-K 2023-03-09 · proof |
- What was Applied Molecular Transport Inc.'s operating income in fiscal 2022?
- Applied Molecular Transport Inc. reported operating income of -$127.2 million for fiscal 2022 (the year ended Dec 31, 2022), against -$100.8 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was Applied Molecular Transport Inc.'s net income in fiscal 2022?
- Applied Molecular Transport Inc. reported net income of -$126.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$100.3 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was Applied Molecular Transport Inc.'s cash from operating activities in fiscal 2022?
- Applied Molecular Transport Inc. reported cash from operating activities of -$93.9 million for fiscal 2022 (the year ended Dec 31, 2022), against -$82.6 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was Applied Molecular Transport Inc.'s free cash flow in fiscal 2022?
- Applied Molecular Transport Inc. reported free cash flow of -$98.1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$84.5 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are Applied Molecular Transport Inc.'s total assets?
- As of Dec 31, 2022, Applied Molecular Transport Inc. reported total assets of $107.4 million, against $214 million a year earlier (-49.8%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are Applied Molecular Transport Inc.'s total liabilities?
- As of Dec 31, 2022, Applied Molecular Transport Inc. reported total liabilities of $46.6 million, against $50.5 million a year earlier (-7.6%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are Applied Molecular Transport Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Applied Molecular Transport Inc. reported cash and cash equivalents of $61.1 million, against $159.8 million a year earlier (-61.7%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1801777&period_type=annual&limit=5"Information only, not investment advice.